Hygeia Healthcare Holdings Co., Limited conducted an on-market buyback of 306,800 ordinary shares on 3 June 2026, paying a total consideration of HKD 3.00 million. The transaction was executed within a price range of HKD 9.70–9.83 per share, with a volume-weighted average repurchase price of HKD 9.77.

Following the repurchase, the company’s issued share capital (excluding treasury shares) decreased to 610.02 million, while treasury shares increased to 8.48 million. The total number of issued shares remained unchanged at 618.50 million. The shares repurchased represent 0.0503% of the outstanding share capital immediately prior to the transaction.

The buyback was made under the authority granted on 27 June 2025, which permits the repurchase of up to 61.85 million shares. To date, Hygeia Healthcare has repurchased 8.48 million shares under this mandate, equivalent to 1.37% of the issued shares as at the mandate date.

In accordance with Hong Kong Listing Rule 10.06(3)(a), the company is subject to a 30-day moratorium on issuing new shares or disposing of treasury shares, ending on 3 July 2026.

The board confirmed that the repurchase complied with all applicable listing rules and regulatory requirements.